Advanced Cardiac Therapeutics nabs $45 mln

Advanced Cardiac Therapeutics Inc, a medical device company focused on treating cardiac arrhythmias, has secured $45 million in funding. Ajax Health led the round with participation from New Enterprise Associates and Questa Capital Management.

2 May 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail